A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit ...

Key Insights Bruker's estimated fair value is US$48.33 based on 2 Stage Free Cash Flow to Equity Current share price ...

Shares of scientific instrument company Bruker (NASDAQ:BRKR). fell 13.8% in the afternoon session after the company released ...

Bruker plans to host its earnings conference call and webcast on Monday, August 4, 2025 at 8:30 a.m. EDT to discuss second quarter 2025 financial results, business developments and on-going cost ...

Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the second quarter ended June 30, 2025 in a range of $795 - $798 million, which implies approximately flat reported ...

Shares of Bruker fell after the company reported preliminary second-quarter results that missed Wall Street's expectations, hurt by what it called weak academic demand and a soft biopharma market in ...

Bruker plans to address segment-level performance, margin details, and ongoing cost actions during its earnings call scheduled for August 4 at 8:30 a.m. EDT. Key focus areas will include order ...

Homeostatic plasticity, the brain's method of preserving equilibrium in neural circuits, relies heavily on spontaneous ...

Find insight on Bruker, Sartorius, Sarepta and more in the latest Market Talks covering Health Care.

Investors in Bruker Corp (Symbol: BRKR) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...